Crohn's Disease Clinical Trials in Dallas, Texas

5 studies are recruiting for crohn's disease in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

   Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study i…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   TDDC - Baylor University Medical Center Gaston Ave, Dallas, Texas

   Locations

   201 in total

   Run by

   Takeda

   See if you can join NCT06233461 on ClinicalTrials.gov

2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

   The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinica…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   Baylor University Medical Center ( Site 5031), Dallas, Texas

   Locations

   499 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06430801 on ClinicalTrials.gov

3. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

   This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 …

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   The University of Texas Southwestern Medical Center-Site Number: 8400098, Dallas, Texas

   Locations

   461 in total

   Run by

   Sanofi

   See if you can join NCT07184931 on ClinicalTrials.gov

4. Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

   This study proposes a randomized prospective study comparing the Kono-S anastomosis to the standard side-to-side anastomosis.This will be a multi-center randomized prospective trial. Patients with Crohn's ileitis or Crohn's ileocolitis requiring resection will be randomized to undergo either the Ko…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Baylor Scott & White Research Institute, Dallas, Texas

   Locations

   15 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT03256240 on ClinicalTrials.gov

5. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

   This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Mirador Therapeutics Selected Site, Dallas, Texas

   Locations

   66 in total

   Run by

   Mirador Therapeutics, Inc.

   See if you can join NCT07113522 on ClinicalTrials.gov